Related Experiment Video
Updated: Jan 20, 2026

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents
Published on: September 16, 2020
Persistent Plus Disease Subsequent to Panretinal Photocoagulation in an Infant With Retinopathy of Prematurity
Insights
Plus disease, a predictor of retinopathy of prematurity (ROP) progression, may persist in premature infants with comorbidities like anemia. This case highlights persistent plus-like disease after ROP treatment.
Area of Science:
- Ophthalmology
- Neonatology
- Medical Imaging
Background:
- Plus disease, characterized by vascular dilation and tortuosity, is a key indicator of retinopathy of prematurity (ROP) progression.
- Resolution of plus disease signifies early ROP regression.
- Comorbidities such as anemia and cardiovascular disease can lead to persistent plus-like disease even after successful ROP treatment.
Purpose of the Study:
- To present a case of persistent plus-like disease in a premature infant following ROP treatment.
- To discuss the implications of comorbidities on ROP management.
Main Methods:
- Case report of a 24-week premature infant.
- Treatment with panretinal photocoagulation for stage 3, zone II ROP.
Main Results:
- The infant presented with persistent plus-like disease despite successful ROP treatment.
- This suggests underlying comorbid conditions may influence disease presentation and resolution.
Conclusions:
- Persistent plus-like disease in ROP patients warrants consideration of comorbid conditions.
- Further investigation into the relationship between comorbidities and ROP progression/regression is needed.
Abstract:
Plus disease, or the presence of vascular dilation and tortuosity, is the most reliable predictor of the progression of retinopathy of prematurity (ROP), making resolution of plus disease one of the earliest signs of ROP regression. Patients with certain comorbid conditions such as anemia and cardiovascular disease may have persistent plus-like disease following successful resolution of ROP. The authors present a case of a 24-week premature infant who was treated with panretinal photocoagulation for stage 3, zone II. [Ophthalmic Surg Lasers Imaging Retina. 2019;50:520-521.].
Related Concept Videos
Drug Dosing: Infants and Children
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Principles of Disease Surveillance
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease: Treatment

